Management of Infantile Hemangiomas: Current Trends

Infantile hemangiomas (IH) are common vascular tumours. IH have a characteristic natural course. They proliferate rapidly during the early infantile period followed by a period of gradual regression over several years. Most of the uncomplicated IH undergo spontaneous involution, with a small proportion of cases requiring intervention. These are children with IH in life-threatening locations, local complications like haemorrhage, ulceration and necrosis and functional or cosmetic disfigurements. Systemic corticosteroids have been the first line of treatment for many years. Recently, non-selective beta-blockers, such as oral propranalol and topical timolol, have emerged as promising and safer therapies. Other treatment options include interferon α and vincristine which are reserved for life-threatening haemangiomas that are unresponsive to conventional therapy. This review mainly focuses on the current trends and evidence-based approach in the management of IH.

• Publication year

  2014

• Venue

  Journal of Cutaneous and Aesthetic Surgery

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4103/0974-2077.138324PMID 25136206PMCID 4134656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Propranolol‐resistant infantile haemangiomas

  2013cited by this paper
• Treatment of infantile capillary hemangioma of the eyelid with systemic propranolol.

  2013cited by this paper
• Superficial Hemangioma: Pulsed Dye Laser Versus Wait‐and‐See

  2013cited by this paper
• Propranolol and Infantile Hemangiomas Four Years Later: A Systematic Review

  2013cited by this paper
• Topical timolol maleate for treatment of infantile haemangiomas: preliminary results of a prospective study

  2013cited by this paper
• CONFLICT OF INTEREST: None declared.

  2013cited by this paper
• Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study

  2013cited by this paper
• Topical Timolol for Small Hemangiomas of Infancy

  2013cited by this paper
• RCT of Timolol Maleate Gel for Superficial Infantile Hemangiomas in 5- to 24-Week-Olds

  2013cited by this paper
• Initiation and Use of Propranolol for Infantile Hemangioma: Report of a Consensus Conference

  2013cited by this paper
• Propranolol in a case series of 174 patients with complicated infantile haemangioma: indications, safety and future directions

  2013cited by this paper
• Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: a randomized controlled study.

  2013cited by this paper
• Topical timolol for infantile hemangioma of the eyelid

  2013cited by this paper
• Propranolol for infantile haemangioma: striking effect in the first weeks.

  2012cited by this paper
• Topical Propranolol Therapy for Infantile Hemangiomas

  2012cited by this paper
• Propranolol treatment of infantile hemangioma: clinical and radiologic evaluations.

  2012cited by this paper
• Lessons from a liver hemangioma registry: subtype classification.

  2012cited by this paper
• Topical propranolol for treatment of superficial infantile hemangiomas.

  2012cited by this paper
• Successful Treatment of Orbital Hemangioma with Propranolol in a 5-Year-Old Girl

  2012cited by this paper
• Efficacy of Oral Prednisolone Use in the Treatment of Infantile Hemangiomas in Indian Children

  2011cited by this paper
• Treatment of Small Superficial Haemangioma with Timolol 0.5% Ophthalmic Solution: A Series of 20 Cases

  2011cited by this paper
• Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis.

  2011cited by this paper
• A Randomized Controlled Trial of Propranolol for Infantile Hemangiomas

  2011cited by this paper
• Mature infantile haemangiomas role for propranolol

  2011cited by this paper
• Status of Propranolol for Treatment of Infantile Hemangioma and Description of a Randomized Clinical Trial

  2011cited by this paper
• Propranolol versus Prednisone in the Treatment of Infantile Hemangiomas: A Retrospective Comparative Study

  2011cited by this paper
• Hepatic Infantile Hemangiomas Treated with Oral Propranolol—A Case Series

  2011cited by this paper
• Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.

  2011cited by this paper
• Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.

  2011cited by this paper
• Oral Propranolol Therapy for Infantile Hemangiomas Beyond the Proliferation Phase: A Multicenter Retrospective Study

  2011cited by this paper
• Demographic and clinical characteristics and risk factors for infantile hemangioma: a Chinese case-control study.

  2011cited by this paper
• Propranolol Therapy in 55 Infants with Infantile Hemangioma: Dosage, Duration, Adverse Effects, and Outcome

  2011cited by this paper
• Prospective study of spinal anomalies in children with infantile hemangiomas of the lumbosacral skin.

  2010cited by this paper
• Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action

  2010cited by this paper
• Propranolol therapy for infantile haemangiomas: review of the literature.

  2010cited by this paper
• Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells.

  2010cited by this paper
• Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution.

  2010cited by this paper
• Using pulsed dual-wavelength 595 and 1064 nm is more effective in the management of hemangiomas.

  2010cited by this paper
• Outcomes of Childhood Hemangiomas Treated with the Pulsed‐Dye Laser with Dynamic Cooling: A Retrospective Chart Analysis

  2009cited by this paper
• Propranolol for Severe Infantile Hemangiomas: Follow-Up Report

  2009cited by this paper
• Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas.

  2009cited by this paper
• Spectrum of hepatic hemangiomas: management and outcome.

  2009cited by this paper
• Growth Characteristics of Infantile Hemangiomas: Implications for Management

  2008cited by this paper
• Propranolol for severe hemangiomas of infancy.

  2008cited by this paper
• Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice.

  2008cited by this paper
• Infantile Hemangiomas: How Common Are They? A Systematic Review of the Medical Literature

  2008cited by this paper
• Oral Versus High-Dose Pulse Corticosteroids for Problematic Infantile Hemangiomas: A Randomized, Controlled Trial

  2007cited by this paper
• Prospective Study of Infantile Hemangiomas: Clinical Characteristics Predicting Complications and Treatment

  2006cited by this paper
• Early Stroke and Cerebral Vasculopathy in Children With Facial Hemangiomas and PHACE Association

  2006cited by this paper
• Comparison study of a traditional pulsed dye laser versus a long‐pulsed dye laser in the treatment of early childhood hemangiomas

  2006cited by this paper
• Intralesional Laser Therapy Treatment for Hemangiomas: Technical Evolution

  2006cited by this paper
• Hemangiomas: new insights and classification.

  2005cited by this paper
• Ultrapotent topical corticosteroid treatment of hemangiomas of infancy.

  2005cited by this paper
• Association of solitary, segmental hemangiomas of the skin with visceral hemangiomatosis.

  2004cited by this paper
• Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas.

  2004cited by this paper
• PHACES syndrome: a review of eight previously unreported cases with late arterial occlusions

  2004cited by this paper
• Spontaneous regression of severe acquired infantile hypothyroidism associated with multiple liver hemangiomas.

  2003cited by this paper
• Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients.

  2003cited by this paper
• Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex.

  2002cited by this paper
• Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis.

  2002cited by this paper
• Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation.

  2001cited by this paper
• Retrospective clinical comparison of hemangioma treatment by flashlamp‐pumped (585 nm) and frequency‐doubled Nd:YAG (532 nm) laser

  2001cited by this paper
• Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas.

  2000cited by this paper
• Complications of systemic corticosteroid therapy for problematic hemangioma.

  1999cited by this paper
• Cerebral vasculopathy and neurologic sequelae in infants with cervicofacial hemangioma: report of eight patients.

  1998cited by this paper
• Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a "beard" distribution.

  1997cited by this paper
• Which hemangiomas to treat--and how?

  1997cited by this paper
• Treatment of proliferative haemangiomas with the 585nm pulsed dye laser

  1996cited by this paper

• Treatment of an eyelid infantile hemangioma with potential ptosis development

  2025cites this paper
• Infantile Hemangioma in Infancy: A Case Study on the Natural Course and Therapeutic Management

  2024influential citation
• Pediatric Orbital and Skull Base Pathology.

  2024cites this paper
• Rare complication – skin atrophy – after systemic conservative therapy of infantile hemangioma

  2024influential citation
• Anesthetic and Airway Management in a Case of Surgical Excision of Recurrent Buccal Hemangioma

  2023cites this paper
• A multi-step approach to the treatment of giant scalp congenital hemangiomas: a report of two cases

  2023cites this paper
• IADVL SIG Pediatric Dermatology (Academy) Recommendations on Hemangioma of Infancy (HOI)

  2023cites this paper
• Unusual Presentation of Multiple Cavernous Hemangiomas of the Head and Neck: A Case Series

  2023cites this paper
• Overview of the Head and Neck Hemangiomas: a 5-year Retrospective Study

  2023cites this paper
• Infantile Hemangioma of the Upper Lip: Report of a Rare Case With a Brief Review of Literature

  2023cites this paper
• The prevalence and risk factors for visceral hemangiomas in children with infantile cutaneous hemangiomas

  2022cites this paper
• Development, characterization, and in vitro evaluation of adhesive fibrous mat for mucosal propranolol delivery

  2021cites this paper
• Propranolol vs. steroids in the treatment of infantile hemangiomas: A meta-analysis

  2021cites this paper
• Postcricoid haemangioma with laryngomalacia in infancy

  2021cites this paper
• Morphological, genetic and clinical correlations in infantile hemangiomas and their mimics

  2021cites this paper
• Craniofacial Microsurgery: An Integrated Approach to Management of Cleft and Craniofacial Syndromes, Surgical Experience, and Insights

  2021cites this paper
• Awareness of Common Pediatric Surgical Entities among Practicing Indian Pediatricians

  2021cites this paper
• Randomised controlled trial: Can topical timolol maleate prevent complications for small superficial infantile haemangiomata in high-risk areas?

  2020cites this paper
• Discussion on Vascular Malformations: Current Progress Toward Drug Therapy

  2020cites this paper
• Infantile Hemangioma: An Updated Review.

  2020cites this paper
• Oral Propranolol in the Treatment of Ulcerated Bleeding Scrotal Arteriovenous Malformation

  2020cites this paper
• Adolescent with behavioural changes: Diagnostic clues?

  2020cites this paper
• Why this long face?

  2020cites this paper
• Safety and Efficacy of Imiquimod in the Treatment of Infantile Hemangioma; a Systematic Review and Meta-Analysis

  2020cites this paper
• Giant Vascular Malformation in an Infant’s Hand

  2019cites this paper
• The sustained and targeted treatment of hemangiomas by propranolol-loaded CD133 aptamers conjugated liposomes-in-microspheres.

  2019cites this paper
• Late-onset capillary hemangioma: A rare occurrence

  2019cites this paper
• Infantile Haemangioma in a ‘Beard’ Distribution: A Case Report

  2018cites this paper
• Curative effect and safety of propranolol combined with prednisone in the treatment of infantile hemangiomas

  2018cites this paper
• Algunas especificidades sobre los hemangiomas externos en niños

  2018cites this paper
• Variations of Dermatological Findings in New-Borns of a Community Hospital in Nepal

  2018cites this paper
• Interventions for infantile haemangiomas of the skin.

  2018cites this paper
• An Initial Overview of Management and Treatment Outcomes for Head and Neck Hemangiomas

  2018cites this paper
• Enhanced rapamycin delivery to hemangiomas by lipid polymer nanoparticles coupled with anti-VEGFR antibody.

  2018cites this paper
• Congenital Progressive Mutilating Hemangioma

  2017cites this paper
• Congenital capillary hemangioma arising from palpebral conjunctiva of a neonate

  2017cites this paper
• Characterization of Hemangioma-initiating Stem Cells

  2017cites this paper
• Magnetic Resonance Imaging of the Soft Tissue Vascular Anomalies in Torso and Extremities in Children: An Update With 2014 International Society for the Study of Vascular Anomalies Classification

  2017cites this paper
• Burn Hemangioma (BH) (Scalded Pyogenic Granuloma) versus Infantile Hemangioma: Report of Six Cases of BH and Its Effective Therapy with Oral Propranolol

  2017cites this paper
• Sonographische Beurteilung kindlicher Hämangiome unter Farbstofflasertherapie

  2017cites this paper
• Approach to Infantile Hemangiomas

  2016cites this paper
• Evolving strategy in treatment of infantile hemangiomas: from steroids to propranolol İnfantil hemanjiyomlarda steroidlerden propranolole gelişen tedavi stratejisi

  2016cites this paper
• Kliničke značajke i modaliteti suvremenog liječenja hemangioma u djece

  2016cites this paper
• Giant Infantile Hemangioma of Neck Managed by Oral Corticosteroids : A Case Report with Review of Literature

  2016cites this paper
• Effect of 22 Novel Cytochrome P450 2D6 (CYP2D6) Variants Found in the Chinese Population on Hemangeol Metabolism In Vitro

  2016cites this paper
• The treatment of problematic hemangiomas in children with propranolol and 940nm diode laser.

  2016cites this paper
• Infantile haemangioma: their presentation and management.

  2015cites this paper
• Current trends in medical management of infantile hemangioma

  2015cites this paper
• Novel treatment for infantile hemangiomas.

  2014cites this paper
• Topical timolol treatment for infantile hemangiomas: a phase II multicentre randomized clinical trial

  2014influential citation
• The Dynamics and Power of Change: Changing Practices in Cutaneous and Aesthetic Surgery

  2014cites this paper
• Topical propranolol cream in treatment of superficial infantile hemangiomas: a literature review and 4 years of clinical experience.

  2014cites this paper
• Management of Infantile Hemangiomas

  2014cites this paper
• An Overview Of Infantile Hemangioma, Symptoms, Causes, Diagnosis And Various Types Of Treatment And Adverse Reaction Of Drugs Used In Treatment.

  year unknowncites this paper
• Outcome of Interventions in Management of Infantile Outcome of Interventions in Management of Infantile Haemangiomas

  year unknowncites this paper